Supernus Pharmaceuticals Other Non-Cash Items 2011-2024 | SUPN
Supernus Pharmaceuticals other non-cash items from 2011 to 2024. Other non-cash items can be defined as miscellaneous non-cash adjustments to Net income.
Supernus Pharmaceuticals Annual Other Non-Cash Items
(Millions of US $) |
| 2024 |
$18 |
| 2023 |
$34 |
| 2022 |
$-11 |
| 2021 |
$20 |
| 2020 |
$16 |
| 2019 |
$11 |
| 2018 |
$5 |
| 2017 |
$26 |
| 2016 |
$-36 |
| 2015 |
$7 |
| 2014 |
$3 |
| 2013 |
$25 |
| 2012 |
$1 |
| 2011 |
$-91 |
| 2010 |
$-1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.872B |
$0.662B |
|
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.
|
